N.J. drugmaker Merck reports new antiviral COVID drug quickly reduces virus
New Jersey-based Merck said Saturday that the experimental antiviral drug molnupiravir it has been developing with Ridgeback Bio showed a quick reduction of the infectious virus in a study among participants with early COVID-19.
Read the rest of this entry » Posted: March 6th, 2021 | Author: NJNewsCommons | Filed under: COVID-19 | Tags: COVID-19, Merck, New Jersey, Ridgeback Bio | Comments Off on N.J. drugmaker Merck reports new antiviral COVID drug quickly reduces virus